Brainstorm Cell Therapeutics, Inc. (BCLI)
0.8219
+0.05
(+5.91%)
USD |
OTCM |
Oct 23, 16:00
Brainstorm Cell Therapeutics Price : 0.8219 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 0.7999 | 0.8336 | 0.7526 | 0.8219 | 28861.00 |
| Oct 22, 2026 | 0.7518 | 0.8349 | 0.7518 | 0.776 | 9513.00 |
| Oct 21, 2026 | 0.7517 | 0.8344 | 0.7517 | 0.77 | 3196.00 |
| Oct 20, 2026 | 0.8065 | 0.8349 | 0.7515 | 0.80 | 18058.00 |
| Oct 19, 2026 | 0.8326 | 0.8326 | 0.7665 | 0.77 | 6848.00 |
| Oct 16, 2026 | 0.835 | 0.835 | 0.7750 | 0.7791 | 7412.00 |
| Oct 15, 2026 | 0.835 | 0.835 | 0.80 | 0.80 | 2480.00 |
| Oct 14, 2026 | 0.77 | 0.835 | 0.7662 | 0.835 | 21143.00 |
| Oct 13, 2026 | 0.8515 | 0.8515 | 0.7662 | 0.8316 | 24364.00 |
| Oct 12, 2026 | 0.87 | 0.935 | 0.85 | 0.8516 | 12787.00 |
| Oct 09, 2026 | 0.93 | 0.96 | 0.88 | 0.9494 | 16421.00 |
| Oct 08, 2026 | 0.892 | 0.96 | 0.892 | 0.9137 | 723.00 |
| Oct 07, 2026 | 0.96 | 0.96 | 0.9001 | 0.9001 | 6271.00 |
| Oct 06, 2026 | 0.95 | 1.03 | 0.95 | 1.03 | 907.00 |
| Oct 05, 2026 | 1.00 | 1.05 | 0.9191 | 1.05 | 11749.00 |
| Oct 02, 2026 | 0.946 | 1.03 | 0.90 | 0.9302 | 16625.00 |
| Oct 01, 2026 | 0.9430 | 1.08 | 0.922 | 1.00 | 17436.00 |
| Sep 30, 2026 | 0.88 | 0.95 | 0.88 | 0.95 | 7748.00 |
| Sep 29, 2026 | 0.92 | 0.92 | 0.92 | 0.92 | 865.00 |
| Sep 28, 2026 | 0.9055 | 0.965 | 0.9055 | 0.936 | 1380.00 |
| Sep 25, 2026 | 0.979 | 0.979 | 0.96 | 0.97 | 20573.00 |
| Sep 24, 2026 | 0.989 | 1.08 | 0.92 | 0.9498 | 18981.00 |
| Sep 23, 2026 | 0.8331 | 0.99 | 0.8331 | 0.8701 | 1652.00 |
| Sep 22, 2026 | 0.87 | 0.9434 | 0.87 | 0.9434 | 2160.00 |
| Sep 21, 2026 | 0.8701 | 0.90 | 0.85 | 0.87 | 17662.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| NovelStem International Corp. | 0.0066 |
| Summit Therapeutics, Inc. | 15.47 |
| Kezar Life Sciences, Inc. | 7.29 |
| Protara Therapeutics, Inc. | 2.33 |
| Clene, Inc. | 3.88 |
Price Related Metrics
| Earnings Yield | -116.1% |
| Market Cap | 9.070M |